Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review

<b>Background:</b> The use of regorafenib and 5-fluorouracil in the management of refractory metastatic colorectal cancer has gained increasing attention due to their demonstrated efficacy in extending the survival of patients with colorectal cancer. This study aims to discuss the effect...

詳細記述

書誌詳細

出版年:	Reports
主要な著者:	Abdullah Esmail, Bayan Khasawneh, Ebtesam Al-Najjar, Raed Zaidan, Maen Abdelrahim
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-04-01
主題:	colorectal cancer metastasis case report regorafenib 5-fluorouracil 5-FU
オンライン･アクセス:	https://www.mdpi.com/2571-841X/8/2/59